Supplementary Figure S5 from Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial

Authors: Christine Desmedt, Ha-Linh Nguyen, François Richard et al.
Publication:
Published: Unknown date
Source: Crossref
Back to Search View Original Cite This Article

Abstract

<jats:p>&lt;p&gt;Transcriptomic differences between non-classic and classic ER+/HER2- ILC.&lt;/p&gt;</jats:p>

Keywords

ptranscriptomic differences nonclassic classic erher2

Related Articles

Supplementary Figure 9 from Targeting the NAD&lt;sup&gt;+&lt;/sup&gt; Salvage Pathway Blocks Metabolic Recovery and Enhances β-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells

Bruce Chang-Gu, Tuvshintugs Baljinnyam et al. - Unknown

Read More
Supplementary Figure S4 from &lt;i&gt;SPEN&lt;/i&gt; Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities

Benedikt Pelzer, Cem Meydan et al. - Unknown

Read More
Supplementary Data S1 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies

Marie-Anne Goyette, Christopher Graser et al. - Unknown

Read More
Supplementary Data 2 from First-In-Human Trial of Encapsulated Cells Constitutively Expressing Localized IL2 in Patients with High-Grade Serous Ovarian Carcinoma

Helen D. Clark, Samira Aghlara-Fotovat et al. - Unknown

Read More
Table S11 from Association between Depression and Risk of Colorectal Cancer and Polyps: A Prospective Cohort Study from the Nurses’ Health Study II

Peenaprapa Tangpradubkiat, Andrea L. Roberts et al. - Unknown

Read More
Journal Ideas PyMinds Charcha More
PORE

About

About Us

Resources

Help Centre Research Guides CiteScore

Legal

Terms of Service Privacy Policy Cookie Policy Accessibility

Connect

Contact Us
© 2026 PORE. Content available under CC BY-NC 4.0